Cargando…
Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial(†)
AIMS: This multicentre, randomized trial compared three strategies of AF ablation: ablation of complex fractionated electrograms (CFE) alone, pulmonary vein isolation (PVI) alone, and combined PVI + CFE ablation, using standardized automated mapping software. METHODS AND RESULTS: Patients with drug-...
Autores principales: | Verma, Atul, Mantovan, Roberto, Macle, Laurent, De Martino, Guiseppe, Chen, Jian, Morillo, Carlos A., Novak, Paul, Calzolari, Vittorio, Guerra, Peter G., Nair, Girish, Torrecilla, Esteban G., Khaykin, Yaariv |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878965/ https://www.ncbi.nlm.nih.gov/pubmed/20215126 http://dx.doi.org/10.1093/eurheartj/ehq041 |
Ejemplares similares
-
Cost of AF Ablation: Where Do We Stand?
por: Khaykin, Yaariv, et al.
Publicado: (2011) -
Cost-effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation: A Canadian Perspective
por: Khaykin, Yaariv, et al.
Publicado: (2016) -
Cost considerations in the management of atrial fibrillation – impact of dronedarone
por: Khaykin, Yaariv, et al.
Publicado: (2012) -
Current Issues in Atrial Fibrillation
por: Khaykin, Yaariv, et al.
Publicado: (2012) -
Cost of Atrial Fibrillation: Invasive vs Non-Invasive Management in 2012
por: Khaykin, Yaariv, et al.
Publicado: (2012)